RE-LIEVED LIDOCAINE PATCH- lidocaine patch 4% patch 
Transfer Technology

----------

Re-Lieved Lidocaine 4% Patch

Active Ingredients

Lidocaine 4%

Menthol 1%

Purpose

Topical Analgesic

Use

For the temporary relief of pain.

Warnings

For external use only.The adhesoin properties of this patch may cause an extended period of redness. Please visit www.re-lieved.com for more information.

Do not use

If you are allergic to Lidocaine. On open wounds or on damaged, broken or irritated skin. Remove immidiately if you sense a burning sensation after application.

When using this product

Ask your doctor or pharmacist before use if you are

using blood thinning medication, steroids, or non-steroidal anti-inflammatory druns (NSAIDs), or if you have sensitive skin.

Stop use or ask a doctor if

If pregnant or breast feeding

ask a physician before use.

Keep out of reach of children

If put in mouth, get medical help or contact a poison control center right away. Dispose of used product away from children and pets.

Directionsadults/children 12 years or older

Other information

Inactive Ingredients

Acrylic adhesive, Polyethylene fabric

Re-Lieved Lidocaine-Menthol

Re-Lieved Lidocaine plus Menthol

RE-LIEVED LIDOCAINE PATCH 
lidocaine patch 4% patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71662-001
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL, (+)- (UNII: C6B1OE8P3W) (MENTHOL, (+)- - UNII:C6B1OE8P3W) MENTHOL, (+)-1 mg  in 100 mg
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 mg  in 100 mg
Inactive Ingredients
Ingredient NameStrength
ACRYLIC ACID/ETHYLENE COPOLYMER (600 MPA.S) (UNII: 1PEZ3NLY6I)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71662-001-065 mg in 1 POUCH; Type 0: Not a Combination Product02/01/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01702/01/2021
Labeler - Transfer Technology (037968132)
Registrant - Transfer Technology (037968132)
Establishment
NameAddressID/FEIBusiness Operations
Transfer Technoloy037968132manufacture(71662-001)

Revised: 10/2024
Document Id: 24b27c05-e17d-083d-e063-6394a90a0fe7
Set id: ba5cd48c-cd43-2f63-e053-2a95a90a930f
Version: 2
Effective Time: 20241017
 
Transfer Technology